[1]
“Cancer Nanotheranostics: Bridging Pharmaceutical Engineering with Pharmacological Targeting”, FMBC, pp. 35–47, Dec. 2025, Accessed: Mar. 02, 2026. [Online]. Available: https://fmbc.nknpub.com/1/article/view/3